San Francisco startup Structure Therapeutics can be engaged on an oral, at the time-each day GLP-one drug known as GSBR-1290—the drug surpassed Wall Street’s expectations in June every time a mid-stage examine showed ordinary weight loss of around 6% and it programs to start out A different mid-stage demo toward the end of the year—that found